Are you Dr. Franklin?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 66 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4650 W Sunset Blvd
Los Angeles, CA 90027Phone+1 323-669-2121Fax+1 323-660-7128
Summary
- Dr. Janet Franklin, MD is a pediatric hematologist/oncologist in Los Angeles, California.
Education & Training
Baylor College of Medicine (Houston)Residency, Pediatrics, 1984 - 1986
Georgetown University School of MedicineClass of 1984
Clinical Trials
- Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia Start of enrollment: 2002 Aug 01
- Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy Start of enrollment: 2003 Dec 01
Publications & Presentations
PubMed
- 2 citationsA Review of the Totality of Evidence for the Development and Approval of ABP 710 (AVSOLA), an Infliximab BiosimilarWalter Reinisch, Stanley N. Cohen, Monica Ramchandani, M. Khraishi, Jennifer Liu
Advances in Therapy. 2021-11-10 - 5 citationsEfficacy and safety of blinatumomab: Post hoc pooled analysis in Asian adults with relapsed/refractory B-cell precursor acute lymphoblastic leukemiaYukio Kobayashi, Iekuni Oh, Toshihiro Miyamoto, Won Sik Lee, Hiroatsu Iida
Asia-Pacific Journal of Clinical Oncology. 2021-06-29 - 19 citationsBiomarkers associated with blinatumomab outcomes in acute lymphoblastic leukemia.Andrew H. Wei, Josep-Maria Ribera, Richard A. Larson, David Ritchie, Armin Ghobadi
Leukemia. 2021-02-04
Press Mentions
ESA 2014: GRS NVCS Mapping - the Future Is Now !!May 18th, 2019
